ClinVar Miner

Submissions for variant NM_006343.3(MERTK):c.2435A>C (p.Tyr812Ser)

dbSNP: rs141361084
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000454548 SCV000539621 uncertain significance not specified 2016-03-29 criteria provided, single submitter clinical testing Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Gene associated with RP - not related to our patient's phenotype. This variant is reported in one individual with Leber congenital amaurosis who carreid a homozygous frameshift variant in another RP gen- RPGRIP1 (Eisenberger_2013_24265693).
Eurofins Ntd Llc (ga) RCV000727047 SCV000705158 uncertain significance not provided 2017-01-12 criteria provided, single submitter clinical testing
Baylor Genetics RCV001331567 SCV001523630 uncertain significance Retinitis pigmentosa 38 2020-06-03 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
Labcorp Genetics (formerly Invitae), Labcorp RCV000727047 SCV001541582 uncertain significance not provided 2022-10-03 criteria provided, single submitter clinical testing This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 812 of the MERTK protein (p.Tyr812Ser). This variant is present in population databases (rs141361084, gnomAD 0.02%). This missense change has been observed in individual(s) with Leber congenital amaurosis (PMID: 24265693). ClinVar contains an entry for this variant (Variation ID: 403082). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MERTK protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000727047 SCV002759018 likely benign not provided 2022-12-02 criteria provided, single submitter clinical testing Reported in an individual with Leber congenital amaurosis who also harbored a homozygous pathogenic variant in another gene responsible for this phenotype (Eisenberger et al., 2013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24265693)
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre RCV001331567 SCV004806292 uncertain significance Retinitis pigmentosa 38 2024-03-25 criteria provided, single submitter clinical testing
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV004816671 SCV005072590 uncertain significance Retinal dystrophy 2020-01-01 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV000727047 SCV005187859 uncertain significance not provided criteria provided, single submitter not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.